Equity Capital Markets

Company · CIK 1834105

IMPACT BIOMEDICAL INC.

CIK1834105 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inNV
Business addressNY
ListedIBO (NYSE)
First annual or quarterly report2023-10-05

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-275062
Registered companyFinal prospectus
2023-10-172024-09-1710
333-253037
First-time registrationEffective
2021-02-122023-08-0416

Filings

26
FiledFilingRegistrationAccession
2024-09-17424B4Final prospectus 333-2750620001493152-24-036520
2024-09-13EFFECTDeclared effective 333-2750629999999995-24-002832
2024-08-27S-1/AAmendment 333-2750620001493152-24-034009
2024-08-20S-1/AAmendment 333-2750620001493152-24-033267
2024-08-09S-1/AAmendment 333-2750620001493152-24-030934
2024-06-11S-1/AAmendment 333-2750620001493152-24-023488
2024-02-28S-1/AAmendment 333-2750620001493152-24-008226
2023-11-21S-1/AAmendment 333-2750620001493152-23-042218
2023-11-01S-1/AAmendment 333-2750620001493152-23-039032
2023-10-17S-1Registration filed 333-2750620001493152-23-037534
2023-08-04EFFECTDeclared effective 333-2530379999999995-23-002278
2023-08-01S-1/AAmendment 333-2530370001493152-23-026281
2023-07-24S-1/AAmendment 333-2530370001493152-23-025388
2023-06-30S-1/AAmendment 333-2530370001493152-23-023121
2023-06-21S-1/AAmendment 333-2530370001493152-23-021957
2023-06-02S-1/AAmendment 333-2530370001493152-23-019982
2023-05-15S-1/AAmendment 333-2530370001493152-23-017566
2023-01-31S-1/AAmendment 333-2530370001493152-23-003170
2023-01-09S-1/AAmendment 333-2530370001493152-23-000961
2022-12-07S-1/AAmendment 333-2530370001493152-22-034778
2022-08-24S-1/AAmendment 333-2530370001493152-22-023938
2022-08-02S-1/AAmendment 333-2530370001493152-22-021049
2022-07-11S-1/AAmendment 333-2530370001493152-22-018988
2022-06-24S-1/AAmendment 333-2530370001493152-22-017756
2021-09-29S-1/AAmendment 333-2530370001493152-21-024112
2021-02-12S-1Registration filed 333-2530370001493152-21-003571

All filings of this company · CSV